Recycling of fatty acids within brain phospholipids is very rapid (half-lives of minutes to hours). Plasma fatty acids make only a small contribution (2-4%) to the net quantity of fatty acids reesterified, making many weeks necessary to restore n-3 PUFA concentrations after prolonged dietary deprivation. Changes in recycling in response to centrally acting drugs help identify enzyme targets for drug action. For example, recycling of arachidonate is specifically reduced by 80% in rats treated chronically with lithium, a drug effective against bipolar disorder; the effect reflects downregulation of gene expression of an arachidonate-specific phospholipase A2. Neuroimaging (quantitative autoradiography in rodents or positron-emission tomography [PET ] in macaques or humans) with intravenously injected radiolabeled fatty acids can localize and quantify neuroplastic remodeling of brain lipid membranes.
Rapoport SI. In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling. J Mol Neurosci 2001 Apr-Jun;16(2-3):243-61; discussion 279-84